Was it natural zoonotic spillover that catapulted SARS-CoV-2 from an emerging virus into a pandemic pathogen or was it something much more sinister? Is it at all possible that a lab leak in Wuhan, China, was the spark that lit the fuse?

Debate and discussion about the origin of the virus that causes COVID-19 have been at the forefront of the global consciousness since the first cases were reported in December 2019.

Early on, whispers of a potentially engineered virus quickly grew to a roar and fueled speculation that China was behind the pandemic. This narrative was so pervasive that, in February 2020, a group of 27 public health scientists 

 disputing the lab leak theory and announcing their support of their counterparts in China: the scientists, public health officials, and medical professionals combating the pandemic.

“The rapid, open, and transparent sharing of data on this outbreak is now being threatened by rumors and misinformation around its origins,” wrote the authors, who all declared no competing interests in their disclosures as recommended by the International Committee of Medical Journal Editors. “We stand together to strongly condemn conspiracy theories suggesting that COVID-19 does not have a natural origin.”

And although it’s true that analyses of the genomic sequence of the virus subsequently pointed to natural origins, the questions regarding China’s role persisted, led by pesky discrepancies and conflicting reports.

Fast forward to June 2021 and new evidence that has breathed new life into those origin questions. In an update to the February 2020 letter, 

 an addendum with revised disclosure statements from virologist and investigator Peter Daszak, one of the 27 authors. In the revised document, Daszak noted that his remuneration is paid solely in the form of a salary from EcoHealth Alliance, a New York-based nonprofit research foundation of which he is president. The company has reportedly worked directly with Wuhan laboratories and funded gain-of-function research at China’s Wuhan Institute of Virology.

Consider, too, other odd associations. Recent reports have uncovered financial ties between Google and EcoHealth Alliance. This comes after accusations that the tech giant was censoring lab leak “conspiracy theory” stories in its search results. Google’s health lead, David Feinberg, has dismissed those reports, insisting that the company is simply taking steps to protect users from unverified information.

Are these coincidences or “where there’s smoke, there’s fire” situations? It’s unclear. But they add to the bank of troublesome questions standing in the way of the truth about COVID-19.

The questions extend beyond origin theory, though. With the US Food and Drug Administration’s green lighting of vaccines for adolescents and young adults comes hesitation over long-term effects: What is the effect on fertility? Do the vaccines cause heart inflammation? Dr. Robert Malone, the inventor of the mRNA technology, appeared on television recently, expressing strong concern over the risk-benefit analysis of vaccination for young adults, and the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices recently met to discuss instances of myocarditis or pericarditis in people aged 30 and younger who have received an mRNA COVID-19 vaccine.

Of course, the answer to our ultimate question is that we may never know.

We may never know where this virus came from. We may never know what triggered the global pandemic that has claimed more than 3.8 million lives. And we won’t know the long-term effects until enough time has elapsed. What we do know for certain is that the incredible strength and collaboration of the scientific community have allowed us to regain some semblance of normalcy. The development and rollout of multiple effective vaccine options have been the medical miracle of our lifetime.

That, right now, will have to be the only answer that matters.

Articles

Is it at all possible that a lab leak in Wuhan, China, was the spark that lit the fuse?

Questions Linger Around COVID-19’s Origin 

It’s been more than a decade since the Institute of Medicine recommended that all cancer survivors receive survivorship care plans, yet many patients still do not receive them. Transitioning out of active cancer treatment can be nerve-racking for many people, but oncology nurses can help by bringing up survivorship care plans early and often with their patients, as well as helping them navigate the often-confusing healthcare system when they are ready to return to their primary care physicians. We explore this important topic in our cover story, “Cancer Survivorship: Right-Sizing Care.”

After treatment, many survivors also develop anxiety around their cancer coming back. This fear of recurrence can be debilitating for people who experience it, and it can have major psychosocial implications. In this issue’s Nurse’s Note, editor in chief Deborah A. Boyle, MSN, RN, AOCNS, FAAN, tackles this important topic, which is all too prevalent in the cancer community. Boyle offers tips that nurses can pass on to patients, and she stresses the importance of bringing up the subject. Even if patients don’t broach the topic themselves, it may still be top of mind.

Our 2 Partner Perspectives also touch on how nurses can aid patients who are experiencing stress and anxiety. One, from our partners at CancerCare, focuses on cancer as trauma, because a diagnosis can definitely qualify as a traumatizing and life-changing event. The other, from Cancer Support Community, focuses on tools, resources, and coping mechanisms that nurses can offer patients facing psychosocial distress.

Also in this issue, our Continuing Education section features updates from the 

, hosted by Physicians’ Education Resource

, LLC, which covered everything nursing professionals need to know, from tumor type basics to adverse event management.

 is enjoyable and helps nurses better help their patients.

The September issue of Oncology Nursing News® offers a wealth of information on how oncology nurses can help their patients navigate psychosocial issues, from the moment of diagnosis and beyond.

Mike Hennessy, Sr, Chairman

Articles

Questions Linger Around COVID-19’s Origin

Nurses Can Address Psychosocial Needs, From Diagnosis to Survivorship